Categories Earnings, Health Care

BSX Earnings: Highlights of Boston Scientific’s Q1 2023 results

Medical device maker Boston Scientific Corporation (NYSE: BSX) reported financial results for the first quarter of 2023. The company also provided guidance for the second quarter and fiscal 2023.

  • First-quarter net sales increased 12% year-over-year on a reported basis to $3.39 billion
  • Net income attributable to stockholders was $300 million or $0.21 per share, compared to $97 million or $0.07 per share last year
  • Adjusted earnings, excluding one-off items, increased to $0.47 per share in the three-month period from $0.39 per share in the year-ago quarter
  • The management expects net sales to increase between 6.5% and 8.5%, on a reported basis, in the second quarter
  • Reported profit is expected to be in the range of $0.23 per share to $0.27 per share in the June quarter
  • The guidance for adjusted second-quarter earnings per share is $0.48-$0.50
  • In the full fiscal year, net sales are expected to grow in the range of 8.5% to 10.5%

Most Popular

Key highlights from Carnival Corporation’s (CCL) Q3 2023 earnings results

Carnival Corporation & plc (NYSE: CCL) reported third quarter 2023 earnings results today. Revenues were $6.9 billion compared to $4.3 billion in the same period last year. On a GAAP basis,

NKE Earnings: Here’s everything you need to know about Nike’s Q1 report

Nike, Inc. (NYSE: NKE) on Thursday reported results for the first three months of fiscal 2024, reporting a modest rise in revenues. The sneaker giant reported net income of $1.45

Key takeaways from Accenture’s (ACN) Q4 2023 earnings report

Shares of Accenture plc (NYSE: ACN) were down 4% on Thursday after the company delivered mixed results for the fourth quarter of 2023 and provided full-year guidance that came below

Add Comment
Viewing Highlight